CONMED CORP (CNMD) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNMD - US2074101013 - Common Stock
40.8 USD
+0.63 (+1.57%)
40.8 USD
0 (0%)
CNMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While CNMD has a great profitability rating, there are some minor concerns on its financial health. CNMD is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year CNMD was profitable.
In the past year CNMD had a positive cash flow from operations.
Of the past 5 years CNMD 4 years were profitable.
CNMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of CNMD (2.77%) is better than 76.34% of its industry peers.
The Return On Equity of CNMD (6.38%) is better than 79.57% of its industry peers.
With a decent Return On Invested Capital value of 5.39%, CNMD is doing good in the industry, outperforming 77.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 8.84%.
The 3 year average ROIC (5.34%) for CNMD is below the current ROIC(5.39%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROIC | 5.39% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
CNMD has a better Profit Margin (4.77%) than 76.88% of its industry peers.
In the last couple of years the Profit Margin of CNMD has grown nicely.
Looking at the Operating Margin, with a value of 9.99%, CNMD is in the better half of the industry, outperforming 78.49% of the companies in the same industry.
In the last couple of years the Operating Margin of CNMD has grown nicely.
CNMD has a Gross Margin of 54.22%. This is comparable to the rest of the industry: CNMD outperforms 51.61% of its industry peers.
CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNMD is destroying value.
The number of shares outstanding for CNMD has been increased compared to 1 year ago.
Compared to 5 years ago, CNMD has more shares outstanding
Compared to 1 year ago, CNMD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.87 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.87, CNMD is in line with its industry, outperforming 58.60% of the companies in the same industry.
CNMD has a debt to FCF ratio of 5.74. This is a neutral value as CNMD would need 5.74 years to pay back of all of its debts.
CNMD has a Debt to FCF ratio of 5.74. This is in the better half of the industry: CNMD outperforms 77.96% of its industry peers.
CNMD has a Debt/Equity ratio of 0.85. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
CNMD has a worse Debt to Equity ratio (0.85) than 73.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.87 |
ROIC/WACC0.87
WACC6.23%
2.3 Liquidity
CNMD has a Current Ratio of 2.10. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
CNMD's Current ratio of 2.10 is in line compared to the rest of the industry. CNMD outperforms 40.86% of its industry peers.
A Quick Ratio of 0.95 indicates that CNMD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.95, CNMD is doing worse than 79.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.49%, which is quite good.
CNMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.44% yearly.
Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 4.61% in the last year.
The Revenue has been growing slightly by 6.47% on average over the past years.
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
Revenue 1Y (TTM)4.61%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
3.2 Future
CNMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.44% yearly.
CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.19% yearly.
EPS Next Y10.38%
EPS Next 2Y4.62%
EPS Next 3Y6.36%
EPS Next 5Y9.44%
Revenue Next Year5.12%
Revenue Next 2Y2.86%
Revenue Next 3Y3.63%
Revenue Next 5Y5.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.03 indicates a reasonable valuation of CNMD.
Compared to the rest of the industry, the Price/Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 94.62% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CNMD to the average of the S&P500 Index (26.92), we can say CNMD is valued rather cheaply.
CNMD is valuated reasonably with a Price/Forward Earnings ratio of 8.96.
Based on the Price/Forward Earnings ratio, CNMD is valued cheaply inside the industry as 95.70% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CNMD to the average of the S&P500 Index (23.46), we can say CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.03 | ||
| Fwd PE | 8.96 |
4.2 Price Multiples
CNMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CNMD is cheaper than 90.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CNMD is valued cheaper than 97.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.5 | ||
| EV/EBITDA | 9.95 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CNMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.87
PEG (5Y)0.96
EPS Next 2Y4.62%
EPS Next 3Y6.36%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.99%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.20, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.70% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, CNMD has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.99% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
CNMD pays out 39.73% of its income as dividend. This is a sustainable payout ratio.
DP39.73%
EPS Next 2Y4.62%
EPS Next 3Y6.36%
40.8
+0.63 (+1.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.32%
Inst Owner Change1.75%
Ins Owners0.29%
Ins Owner Change0.35%
Market Cap1.26B
Revenue(TTM)1.35B
Net Income(TTM)64.32M
Analysts73.33
Price Target49.37 (21%)
Short Float %7.54%
Short Ratio4.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.99% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP39.73%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.52%
Min EPS beat(2)0.37%
Max EPS beat(2)0.66%
EPS beat(4)4
Avg EPS beat(4)6.26%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.08%
EPS beat(12)10
Avg EPS beat(12)-0.4%
EPS beat(16)13
Avg EPS beat(16)0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.61%
PT rev (1m)-10.37%
PT rev (3m)-21.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.42%
EPS NY rev (1m)0.73%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.03 | ||
| Fwd PE | 8.96 | ||
| P/S | 0.94 | ||
| P/FCF | 8.5 | ||
| P/OCF | 7.55 | ||
| P/B | 1.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.95 |
EPS(TTM)4.52
EY11.08%
EPS(NY)4.55
Fwd EY11.16%
FCF(TTM)4.8
FCFY11.77%
OCF(TTM)5.4
OCFY13.24%
SpS43.51
BVpS32.56
TBVpS-12.65
PEG (NY)0.87
PEG (5Y)0.96
Graham Number57.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROCE | 6.7% | ||
| ROIC | 5.39% | ||
| ROICexc | 5.5% | ||
| ROICexgc | 19.04% | ||
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% | ||
| FCFM | 11.04% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.62%
ROICexgc growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 4.09 | ||
| Cap/Depr | 25.13% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.15% | ||
| Profit Quality | 231.2% | ||
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.87 |
F-Score5
WACC6.23%
ROIC/WACC0.87
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
EPS Next Y10.38%
EPS Next 2Y4.62%
EPS Next 3Y6.36%
EPS Next 5Y9.44%
Revenue 1Y (TTM)4.61%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
Revenue Next Year5.12%
Revenue Next 2Y2.86%
Revenue Next 3Y3.63%
Revenue Next 5Y5.19%
EBIT growth 1Y-35.26%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year42.06%
EBIT Next 3Y15.06%
EBIT Next 5YN/A
FCF growth 1Y296.53%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y191.56%
OCF growth 3Y14.3%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
What is the valuation status of CONMED CORP (CNMD) stock?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 7 / 10.
What is the valuation of CONMED CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 9.03 and the Price/Book (PB) ratio is 1.25.
How financially healthy is CONMED CORP?
The financial health rating of CONMED CORP (CNMD) is 3 / 10.